Cargando…
Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine
Autores principales: | O'Connor, Thomas, O'Callaghan-Maher, Mika, Ryan, Paul, Gibson, Gillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673947/ https://www.ncbi.nlm.nih.gov/pubmed/34931172 http://dx.doi.org/10.1016/j.jdcr.2021.11.028 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)